OPEN-LABEL CLINICAL TRIAL TO INVESTIGATE THE SAFETY AND TOLERABILITY OF ALLOGENEIC B-CELL CONCENTRATES FOR IMMUNE RECONSTITUTION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION MEASURED AS RESPONSE TO A ANTEDATED SINGLE VACCINATION: